Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis. De Greef A, Ghislain PD, Baeck M. Eur J Dermatol 2023;33:707-709.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Greef A, Ghislain PD, Baeck M. Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis. Eur J Dermatol 2023;33:707-709.
PMID: 38465563